Targeting the endogenous cannabinoid system to treat chronic neuropathic pain

by Benjamin K Lau, Christopher W Vaughan
Published 2014-03-01

Projection-Target-Defined Effects of Orexin and Dynorphin on VTA Dopamine Neurons

by Corey Baimel, Benjamin K. Lau, Min Qiao, Stephanie L. Borgland
Published 2017-02-01

A new mouse line with reduced GluA2 Q/R site RNA editing exhibits loss of dendritic spines, hippocampal CA1-neuron loss, learning and memory impairments and NMDA receptor-independe...

by Lyndsey M. Konen, Amanda L. Wright, Gordon A. Royle, Gary P. Morris, Benjamin K. Lau, Patrick W. Seow, Raphael Zinn, Luke T. Milham, Christopher W. Vaughan, Bryce Vissel
Published 2020-02-01